| Literature DB >> 28932590 |
Xiongfei Li1, Renwang Liu1, Tao Shi2, Shangwen Dong3, Fan Ren1, Fan Yang1, Dian Ren1, Haiyang Fan1, Sen Wei1, Gang Chen1, Jun Chen1,4, Song Xu1,4.
Abstract
Malignant fibrous histiocytoma (MFH) is an aggressive soft tissue sarcoma known to occur in various organs. Primary MFH arising in the lung is quite rare. Herein we report a case of a 61-year-old male with primary pulmonary MFH and explore the underlying molecular mechanisms by next-generation sequencing (NGS). Five gene mutations in TSC2, ARID1B, CDK8, KDM5C and CASP8 were detected, and the mTOR inhibitor might be an effective treatment for this patient. In addition, we reviewed the scientific literature of approximately 23 primary pulmonary MFH case reports since 1990 and summarized the clinical features and prognosis of this rare pulmonary malignant tumor.Entities:
Keywords: Malignant fibrous histiocytoma (MFH); sarcoma; sequencing; surgery
Year: 2017 PMID: 28932590 PMCID: PMC5594175 DOI: 10.21037/jtd.2017.07.59
Source DB: PubMed Journal: J Thorac Dis ISSN: 2072-1439 Impact factor: 2.895